 |
인쇄하기
취소
|
Daewoong forges strategic tie-up with Takeda
Published: 2012-07-26 06:57:00
Updated: 2012-07-26 06:57:00
Daewoong Pharmaceutical said Tuesday that it has signed with Takeda Korea to exclusively distribute Takeda’s Instanyl (fentanyl) in Korea.
Instanyl is a prescribed intranasal fentanyl spray for the management of breakthrough pain in adult cancer patients already receiving opioid therapy for chronic pain. Instanyl was developed in-house by Nycomed. It was successfully launched in the EU in th...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.